Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Knight Therapeutics Inc
T.GUD
Alternate Symbol(s):
KHTRF
Healthcare
Knight Therapeutics Inc. is a specialty pharmaceutical company. The Company’s principal business activity is developing, acquiring, in-licensing, out-licensing, manufacturing, marketing and distributing pharmaceutical products in Canada, Latin America and select international markets. It finances other life sciences companies and secures product distribution rights for Canada and select...
international markets. The Company invests in life sciences venture capital funds whereby the Company may receive preferential access to healthcare products for Canada and select international markets. It develops pharmaceutical products, including those to treat neglected tropical and rare pediatric diseases. The portfolio consists of pharmaceutical products with molecules and includes both in-licensed products such as Lenvima, Cresemba, Halaven, Trelstar, Akynzeo, Ambisome, Minjuvi, Imvexxy as well as products owned by Knight such as Exelon and Impavido.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSX:GUD)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
•••
Trevor Abes
X
Post by
Trevor Abes
on Dec 04, 2024 4:31pm
Buzz on the Bullboards: Tangible growth stocks
This week, Canada’s main stock index, the TSX, hit a record high thanks to gains in technology and bank stocks.
read article.
(1886)
•••
Possibleidiot01
X
Post by
Possibleidiot01
on Dec 03, 2024 5:20pm
Andrey Omelchak - BNN - PAST TOP PICK
PAST TOP PICK Knight Therapeutics(GUD-T) 03/12/2024 (A Top Pick Sep 10/24, Down 11%) (Note the short timeframe.) One of the cheapest small caps
...more
Options Trading for Retiring: Cash flow in Your Golden years
posted Dec 07, 2024 9:00am by
Bank of Montreal
-
|
To maintain a plan for retiring comfortably, several key strategies must be kept in mind so retirees can continue generating income. These can include covered calls, cash secured puts, selling put-spreads, and buy-write strategies. BMO’s enhanced InvestorLine platform has industry-leading tools and capabilities specifically designed to empower options traders with access to a wealth of educational content. ...read more
(3)
•••
Chianchin
X
Comment by
Chianchin
on Nov 23, 2024 8:31am
RE:RE:RE:RE:So this is where you buy it looks like
Yep they GUD did a private placement at $10, all those investors who bought it lost fortunes.
(8)
•••
wofats
X
Comment by
wofats
on Nov 19, 2024 1:45pm
RE:RE:RE:So this is where you buy it looks like
On March the 3,2014 1,027,000 shares traded at 3.83 I think that was the first day it traded . I think all those shares are in the money Goodman said less than 19 years
...more
(17)
•••
GoldenInvestor
X
Comment by
GoldenInvestor
on Nov 17, 2024 4:34pm
RE:RE:So this is where you buy it looks like
When did Knight Therapeutics go public? how long did Goodman say it would take to build?
(10)
•••
ferret_ca
X
Comment by
ferret_ca
on Nov 16, 2024 3:41pm
RE:So this is where you buy it looks like
LMFAO GUD is now about the same price as it was when it became public 15 years ago, why would anybody in their right mind invest in this mgmnt team, what a joke.
(8)
•••
wofats
X
Post by
wofats
on Nov 16, 2024 12:16pm
So this is where you buy it looks like
The insiders think this is a buy point . ings Filed 2024-11-15 15:45 Tx date 2024-11-12 $GUD Knight Therapeutics Inc.
...more
(3)
•••
Chianchin
X
Comment by
Chianchin
on Nov 15, 2024 5:36pm
RE:Fr GUD to great : more help for ADHD
I have been negative on this turd for a long ..long time but now it may start to fly and reward old and tired investors.
(17)
•••
GoldenInvestor
X
Post by
GoldenInvestor
on Nov 15, 2024 9:28am
Fr GUD to great : more help for ADHD
Across our territories ADHD is huge and growing across kids and adults. Big in canada, bigger in LATAM great new tool in our tool chest. https://nasenjournals.onlinelibrary.wiley.com/doi/full/10
...more
(0)
•••
PressRelease
X
Post by
PressRelease
on Nov 14, 2024 4:30pm
New Press Release - Knight Therapeutics Announces Health Canada Approval for JORNAY PM(TM) to Treat Attention-Deficit Hyperactivity Disorder (ADHD)
MONTREAL, Nov. 14, 2024 (GLOBE NEWSWIRE) -- Knight Therapeutics Inc. (TSX: GUD) ("Knight"), a pan-American (ex-USA) specialty pharmaceutical company, announced today that Health Canada has approved JORNAY PM™, an extended-release formulation of methylphenidate, a stimulant medication for the...
read article.
(17)
•••
GoldenInvestor
X
Post by
GoldenInvestor
on Nov 13, 2024 9:29am
Comparison between Paladin & Knight
Paladin labs 15 years in. -rev $31.8 M EBITDA - $15.9 M Knight Therapeutics 10 years in - $271 million rev EBITDA -over $42 million
...more
(1886)
•••
Possibleidiot01
X
Post by
Possibleidiot01
on Nov 11, 2024 3:13pm
insider buy from marketbeat.com
Knight Therapeutics Inc. (TSE:GUD - Get Free Report) Director Samira Sakhia bought 20,000 shares of Knight Therapeutics stock in a transaction on Monday, November 11th. The shares were acquired at an
...more
(13)
•••
gudisgood
X
Comment by
gudisgood
on Nov 07, 2024 11:50am
RE:Notice of reassessment update
Thanks for pointing this out! It's been a long process.
(13)
•••
gudisgood
X
Comment by
gudisgood
on Nov 07, 2024 11:44am
RE:RE:Unimpressive Q3 - Still Waiting
I'm with you. Although an uneventful quarter in terms of business development, it was a solid quarter in terms of results, and aligns with the financial guidance given earlier. We knew there
...more
(1)
•••
Stockoman1
X
Comment by
Stockoman1
on Nov 07, 2024 10:20am
RE:Unimpressive Q3 - Still Waiting
I hear you. 6 year and still awaiting the day. Maybe when the grandchildren gradute from college !
(7)
•••
EbbFlow88
X
Comment by
EbbFlow88
on Nov 07, 2024 10:17am
RE:Unimpressive Q3 - Still Waiting
I'm actually a bit surprised by the market's reaction. Book value increased to roughly $7.70/share. It's the 3rd straight quarter of operating profit which is the most important metric as
...more
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Are PGM mining stocks an attractive area for your next portfolio allocation?